Preparation method of fenofibrate intermediate

Through the Friedel-Crafts acylation reaction catalyzed by acetyl protection and Lewis acid, the long reaction time, low yield and high environmental pressure in the synthesis of fenofibrate intermediate 4-hydroxy-4'-chlorobenzophenone was solved. Problem, efficient and low-cost preparation is achieved, operating steps are simplified and product purity is improved.

CN119161239APending Publication Date: 2024-12-20SHANDONG NEW TIME PHARMA CO LTD
View PDF 32 Cites 0 Cited by

Patent Information

Application Number
CN202410409175.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-07
Publication Date
2024-12-20

AI Technical Summary

Technical Problem

The synthesis method of the key intermediate 4-hydroxy-4'-chlorobenzophenone in the prior art has problems such as long reaction time, low yield, high production cost, complex operation and high environmental pressure, which is difficult to meet. The demand for industrial production.

Method used

The acetyl-protected material is used to carry out Friedel-Crafts acylation reaction with Lewis acid catalyst under mild conditions. Through temperature control and solvent selection optimization, the synthesis route is simplified, and the isomer generation and the difficulty of removing phenolic methyl ether protecting groups is avoided. Catalysts such as FeCl3 and AlCl3 were then hydrolyzed under alkaline conditions to remove the protective group to achieve efficient preparation.

Benefits of technology

The preparation of 4-hydroxy-4'-chlorobenzophenone with high purity and high yield is achieved, which simplifies the operation steps, reduces production costs, and has a more gentle and environmentally friendly reaction conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004778546620000013
    Figure BDA0004778546620000013
  • Figure BDA0004778546620000021
    Figure BDA0004778546620000021
  • Figure BDA0004778546620000022
    Figure BDA0004778546620000022
Patent Text Reader

Abstract

The invention belongs to the technical field of medicine synthesis, and particularly relates to a preparation method of a fenofibrate intermediate 4-hydroxy-4 '-chlorobenzophenone. Phenyl acetate and 4-chlorobenzoyl chloride are used as starting materials to react and then are hydrolyzed to obtain 4-hydroxy-4 '-chlorobenzophenone, and an acetyl protected material (SM-1) is adopted in the route, so that the reaction steric hindrance can be increased, the problem of isomer generation caused by Friedel-Crafts acylation reaction is effectively avoided, and the yield of 4-hydroxy-4'-chlorobenzophenone is increased. In addition, acetyl is easily removed by hydrolysis under an alkaline condition, the problem that the use amount of Lewis acid needs to be continuously increased due to violent reaction conditions when the phenol methyl ether protecting group is removed can be avoided, and the reaction conditions are milder.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug synthesis, and particularly relates to a method for preparing fenofibrate intermediate 4-hydroxy-4'-chlorobenzophenone. Background Art

[0002] Fenofibrate, also known as Procetofene, is a third-generation phenoxyacetic acid lipid-lowering drug, a fibrate drug, and the first choice for the treatment of hyperlipidemia. The drug was first launched in 1975 and has since been widely used around the world. Its chemical name is 2-methyl-2-(4-(4-chlorobenzoyl)phenoxy)propionic acid isopropyl ester, and its trade name is The drug can reduce the levels of cholesterol, triglycerides (TG), low-protein lipoprotein (LDL) and very low-density lipoprotein (VLDL) in the blood, while increasing the level of high-density lipoprotein (HDL). It is clinically used to treat hyperlipidemia in adults who have not responded well to dietary control therapy.

[0003] Fenofibrate choline salt is also one of the commonly used lipid-lowering drugs in clinical practice. Fenofibrate choline salt is a complex salt formed by the active metabolite of fenofibrate in the body, fenofibric acid (with a half-life of about 20 hours) and choline. Its solubility under alkaline conditions is significantly higher than that of fenofibrate. In 2008, the US FDA first approved Abbott's fenofibrate choline salt capsules for marketing under the trade name Fenofibric acid choline salt can reduce the levels of low-density lipoprotein (LDL) and triglycerides in the body, increase the level of high-density lipoprotein (HDL), and can also be used in combination with other statins to improve the symptoms of hyperlipidemia. The relevant chemical structure is as follows:

[0004]

[0005] At present, the synthesis methods of fenofibrate mainly include the following:

[0006] ① Etherification method. Literature "Study on Improvement of Synthesis Process of Prosofen", Modern Commerce and Industry, 2009: 21(02), 300-301 and patents CN116554014A, CN104478717A, US6897333B2 (same family WO02062743A1, EP1366013B1), US4739101A (same family EP0245156A1), US417 9515A (same family FR2300552A1, US4072705A), US20070238894A1 (same family EP1837327A1), etc. use 2-bromo-2-methylpropionic acid as raw material, and undergo esterification reaction with isopropanol to generate 2-bromo-2-methylpropionic acid isopropyl ester, and 2-bromo-2-methylpropionic acid isopropyl ester is then substituted with 4-hydroxy-4'-chlorobenzophenone to generate fenofibrate. This method has mild reaction conditions and the product purity meets the requirements, but it needs to react for about 40 hours, and has the disadvantages of low yield and long reaction time. The synthetic route is as follows:

[0007]

[0008] ② Coupling method. Chinese invention patent CN111072478B uses 2-methyl-2-(4-carboxyphenoxy) propionic acid isopropyl ester and 1-bromo-4-chlorobenzene as raw materials, di[2-(2,4-difluorophenyl)-5-trifluoromethylpyridine[2-2'-bi(4-tert-butylpyridine)]iridium di(hexafluorophosphate) salt ([Ir(dF(CF3)ppy)2(dtbbpy)]PF6) as photocatalyst, triphenylphosphine as deoxidizer, ethylene glycol dimethyl ether nickel bromide (NiBr2dme) as catalyst, 4,4'-di-tert-butyl-2,2"-bipyridine (L1) as ligand, potassium phosphate as base, N,N-dimethylformamide and acetonitrile as solvent, under blue light irradiation (45W, λ max =455nm), under argon protection, react at 25°C for 20h to obtain fenofibrate, and the total yield of fenofibrate is 65%. The synthetic route is as follows:

[0009]

[0010] In the literature ACS Catal., 2018, 8, 4, 3123-3128, fenofibrate was prepared by synthesizing diaryl ketones by palladium-catalyzed CH bond activation using 2-(4-bromophenoxy)-2-methylpropionic acid isopropyl ester and p-chlorobenzaldehyde as starting materials. The synthetic route is as follows:

[0011]

[0012] The literature Chem. Commun., 2015, 51, 9133-9136 uses 2-(4-iodophenoxy)-2-methylpropionic acid isopropyl ester and potassium trifluoroborate derivatives as starting materials to prepare fenofibrate by atmospheric pressure carbonylation cross-coupling reaction. The synthetic route is as follows:

[0013]

[0014] J.Org.Chem., 2013, 78, 20, 10310-10318 Fenofibrate was prepared by Suzuki reaction with 2-(4-iodophenoxy)-2-methylpropionic acid isopropyl ester and 4-chlorophenylboronic acid as substrates, carbon monoxide as carbonyl source, PdCl2 as catalyst, and K2CO3 as base, with an overall yield of 85%. The synthetic route is as follows:

[0015]

[0016] The literature Org.Lett., 2014, 16, 7, 1888-1891 makes the borate ester starting material contain a basic group, which can avoid the addition of base. The synthesis route is as follows:

[0017]

[0018] The literature Nature Chemistry, 2018, 10(2), 193-199 uses silver catalysis to activate the CH bond of aromatic hydrocarbons to achieve intermolecular carbonylation, and then synthesize ketones to prepare fenofibrate. The synthesis route is as follows:

[0019]

[0020] The above coupling methods cannot avoid the use of precious metal catalysts or complex ligands, and the reaction conditions are slightly harsh. In addition, the relevant coupling reaction materials need to be prepared separately, or a gas-liquid two-phase reaction involving highly toxic CO is used, which is dangerous to operate and is not suitable for industrial production.

[0021] ③ Phase transfer catalysis. References: "Synthesis of fenofibric acid catalyzed by TEBA", Synthetic Chemistry, 2009: 17(6), 759-760, "Study on the synthesis of fenofibrate catalyzed by sodium bisulfate", Chemical World, 2009: 50(7), 424-426+448, "Study on the synthesis of fenofibrate catalyzed by NKC-9", Guangdong Chemical Industry, 2014: 41(21), 82+99, "SO -24 / Optimization of the process of synthesizing fenofibrate catalyzed by ZrO2, Chemical Engineering and Equipment, 2014(05), 26-27, "Phase transfer catalytic synthesis of fenofibrate acid", Guangzhou Chemical Industry, 2014: 42(21), 102-104, "Optimization of the process of synthesizing fenofibrate catalyzed by sodium bisulfate", Guangzhou Chemical Industry, 2014: 42(9), 101-102+127, "Green synthesis of lipid-lowering drug fenofibrate", Guangzhou Chemical Industry, 2014: 42(23), 90-92, "Synthesis and characterization of fenofibrate", Chemical World, 2015: 56(08), 488-490+505, "Improvement of the synthesis process of lipid-lowering drug fenofibrate", Fine Chemicals, 202 3:40(07),1505-1512 and patents CN110483270A, CN109651144A, CN104311422B, CN104276950B, CN103951557B, CN101730675A, CN110483270B, US2010185008A1, etc. use 4-hydroxy-4'-chlorobenzophenone as raw material, in the presence of alkali and phase transfer catalyst (TEBA, etc.), chloroform and acetone to produce fenofibric acid by carbene addition reaction, and then fenofibric acid and isopropanol are reacted in the presence of catalyst [sulfuric acid, sodium bisulfate, NKC-9 (macroporous strong acid styrene cation exchange resin), SO -2 Fenofibrate is produced by esterification reaction under the action of 4 / ZrO2 solid acid, sodium bisulfate, sodium bisulfate monohydrate, D72 (macroporous strong acid cation exchange resin), magnetic nano solid superacid, thionyl chloride, etc. Compared with the ether synthesis method and the transition metal catalysis method, the phase transfer catalysis method has the advantages of short reaction time and simple operation. The synthesis route is as follows:

[0022]

[0023] ④Other methods. U.S. Patent US2012065421A1 directly reacts fenofibric acid with 2-bromopropane to form an ester to prepare fenofibrate. The synthesis route is as follows:

[0024]

[0025] As can be seen from the above, 4-hydroxy-4'-chlorobenzophenone (CBP) is used as a key intermediate in the synthesis of the lipid-lowering drug fenofibrate in multiple routes. Therefore, 4-hydroxy-4'-chlorobenzophenone can directly affect the production, market supply and quality of the drug. In addition, CBP is also a raw material for pesticide products and the preparation of heat-resistant polymers, and has a wide range of uses. The specific structural formula is shown below:

[0026]

[0027] The main synthesis methods are as follows:

[0028] Literature: "Synthesis of lipid-lowering drug Proshifen". Pharmaceutical Industry, 1982, (6): 5-6, "One-pot preparation of 4-hydroxy-4'-chlorobenzophenone". China Pharmaceutical Industry Journal, 1989, 20 (5): 196, "Improvement of synthesis process of 4-hydroxy-4'-chlorobenzophenone". China Pharmaceutical Industry Journal, 1994, 25 (3): 108, "Study on improvement of synthesis process of 4-hydroxy-4'-chlorobenzophenone". Chemical World, 2010, 51 (5): 295-298 + 306, "Synthesis of 4-hydroxy-4'-chlorobenzophenone catalyzed by AlCl3". Guangzhou Chemical Industry, 2014, 42 (20): 91 -93, "Improvement of the Synthesis Process of Fenofibrate, a Lipid-Lowering Drug". Fine Chemicals, 2023, 40(7): 1505-1512, Euro. J. Med. Chem., 2016, 120, 338-352 and patents US4179515A (same family FR2300552A1, US4072705A), CN106278842B, CN110668928A, CN116554014A, etc. use anisole and p-chlorobenzoyl chloride as starting materials, first undergo Friedel-Crafts acylation reaction and then demethylate to prepare, which is a production process still widely used in China. Although this process itself is constantly improving, it is generally limited to domestic self-use due to the difficulty in removing the product color and the high cost of raw materials. In addition, since phenol methyl ether is difficult to remove, a large amount of AlCl3 needs to be used, which greatly increases the environmental pressure. The synthesis route is as follows:

[0029]

[0030] Patents EP1903024A1, JP04089447A, JP03127753A and literature J.Sci.Ind.Res.India., 1956, 15B, 633-635, "Improvement of Synthesis Process of 4-Hydroxy-4'-Chlorobenzophenone". Chinese Journal of Pharmaceutical Industry, 1995, 26(12): 553, etc. use phenol and p-chlorobenzoyl chloride as starting materials, and then use AlCl3 or CF3SO3H as catalyst to perform Fries rearrangement to prepare 4-hydroxy-4'-chlorobenzophenone. Since the cost of these two catalysts is inversely proportional to the quality of the synthesized product, they cannot meet the requirements of high quality and low price of the product at the same time. The synthesis route is as follows:

[0031]

[0032] Patent JP03041047A and the document "Synthesis of High-Purity 4-Hydroxy-4'-Chlorobenzophenone". Journal of Zhejiang University of Technology, 2000, 28(2):138-141 synthesize 4-hydroxy-4'-chlorobenzophenone by direct reaction of chlorobenzene with p-hydroxybenzoic acid or Friedel-Crafts acylation with p-hydroxybenzoyl chloride. However, this method has the disadvantages of low yield and difficulty in separating ortho-isomers. The synthetic route is as follows:

[0033]

[0034] Patent CN106242956A (CN105541578A) In a methylamine solution, anisole reacts with p-chlorobenzamide under the catalysis of cuprous chloride to obtain 4-chloro-4-methoxybenzophenone, and finally removes the methyl group under the catalysis of CuCl to obtain 4-hydroxy-4'-chlorobenzophenone. This method requires a large amount of highly irritating methylamine solution. The synthesis route is as follows:

[0035]

[0036] The literature J.Am, Chem. Soc., 2017, 139, 8, 2896-2899 uses p-chlorophenylacetylene as the starting material and oxidatively couples it with phenol under CuCl and blue light catalysis to prepare 4-hydroxy-4'-chlorobenzophenone. However, this route has the problem that the key alkyne reagent is difficult to obtain, which makes the production cost high. The synthetic route is as follows:

[0037]

[0038] In summary, given the many problems mentioned above in the reported technical methods for preparing fenofibrate key intermediate 4-hydroxy-4'-chlorobenzophenone, it is still a problem that needs to be solved to study and find a method for preparing fenofibrate key intermediate 4-hydroxy-4'-chlorobenzophenone with mild reaction conditions, simple operation process, high product yield, high purity and low production cost suitable for industrial production. Summary of the invention

[0039] In order to overcome the defects of the prior art, a better method for preparing 4-hydroxy-4'-chlorobenzophenone, a key intermediate of fenofibrate, is sought. The purpose of the present invention is to provide a new method for preparing 4-hydroxy-4'-chlorobenzophenone, a key intermediate of fenofibrate. The target product prepared by the method has high purity and yield, mild reaction conditions, simple operation process and lower production cost.

[0040] The specific technical contents of the present invention are as follows:

[0041]

[0042] A method for preparing 4-hydroxy-4'-chlorobenzophenone, a key intermediate of fenofibrate as shown in formula (I), comprises the following steps:

[0043] Step 1: At room temperature, add compound SM-1 and compound SM-2 to the reaction solvent, stir and mix the materials, control the temperature to T1, add Lewis acid catalyst, and continue to control the temperature to T2 to react after the addition is completed. After the reaction is completed, pour the reaction solution into ice water, separate the liquid, take the organic phase, wash the organic phase with saturated sodium bicarbonate solution, saturated citric acid solution, saturated brine, concentrate to dryness under reduced pressure, and recrystallize from methanol to obtain intermediate I-1;

[0044] Step 2: At room temperature, add the intermediate compound I-1 and sodium hydroxide to methanol, control the temperature to 25-30°C, and after the reaction is completed, adjust the pH to 2-4 with dilute hydrochloric acid, stir and crystallize, and filter. The filter cake is dried under reduced pressure to obtain the target product I.

[0045] In a preferred embodiment, the reaction solvent in step 1 is selected from dichloromethane, chloroform or a combination thereof, wherein dichloromethane is particularly preferred; the organic solvent in step 2 is selected from methanol, ethanol, water or a combination thereof, wherein methanol is particularly preferred.

[0046] In a preferred embodiment, the Lewis acid catalyst in step 1 is selected from one or a combination of AlCl3, FeCl3, ZnCl2, TiCl4, SnCl2, among which FeCl3 is particularly preferred.

[0047] In a preferred embodiment, the molar ratio of the compound SM-1, the compound SM-2 and the Lewis acid catalyst in step 1 is 1:1.05-1.4:1.5-3.5, with 1:1.2:2.0 being particularly preferred.

[0048] In a preferred embodiment, the temperature T1 in step 1 is -10 to 10°C, with 0 to 5°C being particularly preferred; the reaction temperature T2 is 15 to 50°C, with 20 to 25°C being particularly preferred; and the reaction temperature T3 in step 2 is 15 to 50°C, with 25 to 30°C being particularly preferred.

[0049] Compared with the prior art, the technical effects achieved by the present invention are:

[0050] 1. A simple and efficient method for preparing 4-hydroxy-4'-chlorobenzophenone, a key intermediate of fenofibrate, is provided. The entire synthetic method has a short route, simple operation steps and high reaction yield;

[0051] 2. The use of acetyl-protected materials (SM-1) can not only increase the reaction steric hindrance, thereby effectively avoiding the problem of isomer generation caused by Friedel-Crafts acylation reaction, but also the acetyl group can be easily removed by hydrolysis under alkaline conditions, and can also avoid the problem of severe reaction conditions when removing the phenol methyl ether protecting group, and the need to continue to increase the amount of Lewis acid. The reaction conditions are milder and more environmentally friendly. DETAILED DESCRIPTION

[0052] The present invention is further illustrated by the following examples. It should be correctly understood that the examples of the present invention are only used to illustrate the present invention, rather than to limit the present invention. Therefore, simple improvements to the present invention based on the method of the present invention all fall within the scope of protection claimed by the present invention.

[0053] Preparation of Compound I-1

[0054] Example 1

[0055] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 21.00 g, 0.12 mol) were added to dichloromethane (150 mL). After the materials were stirred and mixed, FeCl3 (32.44 g, 0.20 mol) was added at 0-5 °C. After the addition was completed, the temperature was continued to be controlled at 20-25 °C for reaction. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 98.5% and a purity of 99.95%.

[0056] Example 2

[0057] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 18.38 g, 0.105 mol) were added to chloroform (150 mL). After the materials were stirred and mixed, AlCl3 (26.67 g, 0.20 mol) was added at -10 to -5 °C. After the addition was completed, the temperature was continued to be controlled at 20 to 25 °C for reaction. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 94.3% and a purity of 99.65%.

[0058] Example 3

[0059] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 24.50 g, 0.14 mol) were added to chloroform (150 mL). After the materials were stirred and mixed, ZnCl2 (27.26 g, 0.20 mol) was added at 5-10 °C. After the addition was completed, the temperature was continued to be controlled at 20-25 °C for reaction. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 95.4% and a purity of 99.60%.

[0060] Example 4

[0061] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 21.00 g, 0.12 mol) were added to dichloromethane (150 mL). After the materials were stirred and mixed, TiCl4 (28.45 g, 0.15 mol) was added at a temperature of 0-5 ° C. After the addition was completed, the temperature was continued to be controlled at 15-20 ° C. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 94.9% and a purity of 99.71%.

[0062] Example 5

[0063] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 21.00 g, 0.12 mol) were added to dichloromethane (150 mL). After the materials were stirred and mixed, SnCl2 (66.36 g, 0.35 mol) was added at 0-5 °C. After the addition was completed, the temperature was continued to be controlled at 45-50 °C for reaction. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 95.3% and a purity of 99.57%.

[0064] Example 6

[0065] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 17.50 g, 0.10 mol) were added to dichloromethane (150 mL). After the materials were stirred and mixed, the temperature was controlled at -15 to -10 ° C, and FeCl3 (21.09 g, 0.13 mol) was added. After the addition was completed, the temperature was continued to be controlled at 10 to 15 ° C. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 86.4% and a purity of 98.84%.

[0066] Example 7

[0067] At room temperature, phenyl acetate (compound SM-1, 13.62 g, 0.10 mol) and p-chloroacetyl chloride (compound SM-2, 28.00 g, 0.16 mol) were added to dichloromethane (150 mL). After the materials were stirred and mixed, the temperature was controlled at 10-15 ° C and FeCl3 (60.01 g, 0.37 mol) was added. After the addition was completed, the temperature was continued to be controlled at 50-55 ° C. After the reaction was completed, the reaction solution was poured into ice water (200 mL), separated, and the organic phase was taken. The organic phase was washed with saturated sodium bicarbonate solution (50 mL), saturated citric acid (50 mL), and saturated brine (50 mL). After being concentrated to dryness under reduced pressure, it was recrystallized from methanol to obtain intermediate I-1 with a yield of 88.5% and a purity of 97.35%.

[0068] Preparation of Compound I

[0069] Example 8

[0070] At room temperature, intermediate I-1 (13.74 g, 0.05 mol) and NaOH (4.00 g, 0.10 mol) were added to methanol (150 mL), and the temperature was controlled at 25-30 ° C. After the reaction was completed, the pH was adjusted to 3 with dilute hydrochloric acid, and the mixture was stirred for crystallization and filtered. The filter cake was dried under reduced pressure to obtain the target product I with a yield of 98.6% and a purity of 99.95%.

Claims

1. A method for preparing a key intermediate of fenofibrate, characterized in that: The preparation method comprises the following steps: Step 1: At room temperature, add compound SM-1 and compound SM-2 to the reaction solvent, stir and mix the materials, control the temperature to T1, add Lewis acid catalyst, and continue to control the temperature to T2 to react after the addition is completed. After the reaction is completed, pour the reaction solution into ice water, separate the liquid, take the organic phase, wash the organic phase with saturated sodium bicarbonate solution, saturated citric acid solution, saturated brine, concentrate to dryness under reduced pressure, and recrystallize from methanol to obtain intermediate I-1; Step 2: Add the intermediate compound I-1 and sodium hydroxide to methanol at room temperature, and react at 25-30°C. After the reaction is completed, adjust the pH with dilute hydrochloric acid, stir and crystallize, and filter. The filter cake is dried under reduced pressure to obtain the target product I. The reaction route is as follows:

2. The preparation method according to claim 1, characterized in that: The reaction solvent in step 1 is selected from one of dichloromethane and chloroform or a combination thereof; the organic solvent in step 2 is selected from one of methanol, ethanol and water or a combination thereof.

3. The preparation method according to claim 1, characterized in that: The Lewis acid catalyst described in step 1 is selected from one or a combination of AlCl3, FeCl3, ZnCl2, TiCl4, SnCl2.

4. The preparation method according to claim 1, characterized in that: The molar ratio of the compound SM-1, the compound SM-2 and the Lewis acid catalyst in step 1 is 1:1.05-1.4:1.5-3.

5.

5. The preparation method according to claim 1, characterized in that: The temperature T1 described in step 1 is -10 to 10°C, with 0 to 5°C being particularly preferred; and the reaction temperature T2 is 15 to 50°C.

Citation Information

Patent Citations

  • Method for producing fenofibrate

    CN101730675A

  • A kind of method using inorganic base as catalyst to prepare fenofibric acid

    CN103951557B

  • A method for preparing fenofibrate with intelligent temperature control and remote monitoring

    CN104276950B

  • A method for preparing fenofibrate, a lipid-lowering drug

    CN104311422B

  • Purification method of fenofibrate

    CN104478717A